Trial intelligence / Profile preview

Nimodipine and 5G Effects on Sleep

NCT06998368Recruiting

Start
Oct 2024
Primary completion
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of nimodipine (24 arms). Primary endpoint: Sleep spindle center frequency. Started Oct 2024; status: recruiting.

02

Drugs

nimodipine

Beyond the preview

Go deeper on NCT06998368.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06998368.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call